Millipore Sigma Vibrant Logo

OP07 Anti-v-Src (Ab-1) Mouse mAb (327)

This Anti-v-Src (Ab-1) Mouse mAb (327) is validated for use in Immunoblotting, Immunoprecipitation, Frozen Sections, Immunofluorescence, Paraffin Sections for the detection of v-Src (Ab-1).

Anti-v-Src (Ab-1) Mouse mAb (327): のSDS（安全データシート）、CoA（試験成績書）およびCoQ（品質証明書）、カタログなど製品関連の技術資料を入手いただけます。
View This Product on Sigma-Aldrich
OP07
価格＆在庫状況を照会

概要

Replacement Information

主要スペック表

Species ReactivityHostAntibody Type
H, M, RMMonoclonal Antibody

価格＆在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
OP07-100UGCN
在庫状況検索中…
—
現在国内在庫なし 現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      		 樹脂ｱﾝﾌﾟﾙ 100 μg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示　
      値引
      ()
       
      —
      弊社照会
      		 —
      Description
      OverviewRecognizes the ~60 kDa v-Src and c-Src proteins in NIH/3T3 and HT1080 cells. May appear as a doublet due to phosphorylation.
      Catalogue NumberOP07
      Brand Family Calbiochem®
      References
      ReferencesCourtneidge, S.A. and Heber, A. 1987. Cell 50, 1031.
      Cartwright, C.A., et al. 1985. Mol. Cell. Biol. 5,, 2647.
      Courtneidge, S.A. 1985. EMBO J. 4, 1471.
      Whitman, M., et al. 1985. Nature 315, 239
      Bolen, J.B., et al. 1984. Cell 38, 767.
      Hunter, T. and Sefton, B. 1980. Proc. Natl. Acad. Sci. 77, 1311.
      Collett, M.S. et al. 1979. Proc. Natl. Acad. Sci. 76, 3159.
      Collett, M.S. and Erikson, R.L. 1978. Proc. Natl. Acad. Sci. 75, 2021.
      Collett, M.S., et al. 1978. Cell 15, 1363.
      Product Information
      FormLiquid
      FormulationIn 50 mM sodium phosphate buffer, 0.2% gelatin, pH 7.4.
      Positive controlNIH/3T3 cells
      Preservative≤0.1% sodium azide
      Quality LevelMQ100
      Applications
      Application ReferencesImmune Kinase Reaction Bolen, J.B. et al. 1985. Proc. Natl. Acad. Sci. 82, 7275. Immunoblotting Lipsich, L.A., et al. 1983. J. Virol. 48, 352. Grandori, C., and Hanfusa, H. 1988. J. Cell Biol. 107, 2125. Immunoprecipitation Grandori, C., and Hanfusa, H. 1988. J. Cell Biol. 107, 2125. Lipsich, L.A., et al. 1983. J. Virol. 48, 352. Original Clone Lipsich, L.A., et al. 1983. J. Virol. 48, 352.
      Key Applications Immunoblotting (Western Blotting)
      Immunoprecipitation
      Not Frozen Sections
      Not Immunofluorescence
      Not Paraffin Sections
      Application NotesImmunoblotting (2.5 µg/ml, see application references)
      Immunoprecipitation (1 µg antibody or use Cat. No. OP07A; see application references)
      Frozen Sections (not recommended)
      Immunofluorescence (not recommended)
      Paraffin Sections (not recommended)
      Application Commentspp60src may appear as a doublet due to phosphorylation. This antibody can be used to precipitate active src kinase (see application references). The agarose conjugate, Cat. No. OP07A, is available separately for immunoprecipitation. Antibody should be titrated for optimal results in individual systems.
      Biological Information
      Immunogenpurified v-Src
      Epitopewithin the SH3 domain of v-Src and c-Src
      Clone327
      HostMouse
      IsotypeIgG₁
      Species Reactivity
      • Human
      • Mouse
      • Rat
      Antibody TypeMonoclonal Antibody
      Concentration Label Please refer to vial label for lot-specific concentration
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Blue Ice Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Do not freeze Yes
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      OP07-100UGCN 04055977225006

      Documentation

      Anti-v-Src (Ab-1) Mouse mAb (327) (M)SDS

      タイトル

      英語版製品安全データシート（(M)SDS） 

      Anti-v-Src (Ab-1) Mouse mAb (327) 試験成績書（CoA）

      タイトルロット番号
      OP07

      参考資料

      参考資料の概要
      Courtneidge, S.A. and Heber, A. 1987. Cell 50, 1031.
      Cartwright, C.A., et al. 1985. Mol. Cell. Biol. 5,, 2647.
      Courtneidge, S.A. 1985. EMBO J. 4, 1471.
      Whitman, M., et al. 1985. Nature 315, 239
      Bolen, J.B., et al. 1984. Cell 38, 767.
      Hunter, T. and Sefton, B. 1980. Proc. Natl. Acad. Sci. 77, 1311.
      Collett, M.S. et al. 1979. Proc. Natl. Acad. Sci. 76, 3159.
      Collett, M.S. and Erikson, R.L. 1978. Proc. Natl. Acad. Sci. 75, 2021.
      Collett, M.S., et al. 1978. Cell 15, 1363.

      引用

      Title
    • Meenalakshmi M. Mariappan, et al. (2005) Phospholipase Cγ-Erk Axis in Vascular Endothelial Growth Factor-Induced Eukaryotic Initiation Factor 4E Phosphorylation and Protein Synthesis in Renal Epithelial Cells. Journal of Biological Chemistry 280, 28402-28411.
    • Justin M. Summy, et al. (2005) AP23846, a novel and highly potent Src family kinase inhibitor, reduces vascular endothelial growth factor and interleukin-8 expression in human solid tumor cell lines and abrogates downstream angiogenic processes. Molecular Cancer Therapeutics 4, 1900-1911.
    • Jose G. Trevino, et al. (2005) Expression and activity of Src regulate interleukin-8 expression in pancreatic adenocarcinoma cells: implications for angiogenesis. Cancer Research 65, 7214-7222.
      		•
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision01-October-2007 RFH
      ApplicationImmunoblotting (2.5 µg/ml, see application references)
      Immunoprecipitation (1 µg antibody or use Cat. No. OP07A; see application references)
      Frozen Sections (not recommended)
      Immunofluorescence (not recommended)
      Paraffin Sections (not recommended)
      DescriptionPurified mouse monoclonal generated by immunizing BALB/c mice with the specified immunogen and fusing splenocytes with P3X63 Ag8.653 myeloma cells (see application references). Recognizes the ~60 kDa Src protein.
      BackgroundThe major translational product of the avian sarcoma virus has been designated pp60src. Avian sarcoma virus pp60src possesses a characteristic protein kinase activity with specificity for tyrosine residues. The mammalian cellular homologue of pp60src, designated pp60c-src, exhibits a similar protein tyrosine kinase activity which can be activated by interaction with polyoma virus-encoded middle T antigen. Immunoprecipitates of middle T antigen also contain phosphatidylinositol kinase activity coinciding with the presence of a 81 kDa (p81) protein. The p81 is phosphorylated by activated pp60c-src and is thought to be the phosphatidylinositol kinase.
      HostMouse
      Immunogenpurified v-Src
      Epitopewithin the SH3 domain of v-Src and c-Src
      Clone327
      IsotypeIgG₁
      Specieshuman, mouse, rat
      Positive controlNIH/3T3 cells
      FormLiquid
      FormulationIn 50 mM sodium phosphate buffer, 0.2% gelatin, pH 7.4.
      Concentration Label Please refer to vial label for lot-specific concentration
      Preservative≤0.1% sodium azide
      Commentspp60src may appear as a doublet due to phosphorylation. This antibody can be used to precipitate active src kinase (see application references). The agarose conjugate, Cat. No. OP07A, is available separately for immunoprecipitation. Antibody should be titrated for optimal results in individual systems.
      Storage +2°C to +8°C
      Do Not Freeze Yes
      Toxicity Standard Handling
      ReferencesCourtneidge, S.A. and Heber, A. 1987. Cell 50, 1031.
      Cartwright, C.A., et al. 1985. Mol. Cell. Biol. 5,, 2647.
      Courtneidge, S.A. 1985. EMBO J. 4, 1471.
      Whitman, M., et al. 1985. Nature 315, 239
      Bolen, J.B., et al. 1984. Cell 38, 767.
      Hunter, T. and Sefton, B. 1980. Proc. Natl. Acad. Sci. 77, 1311.
      Collett, M.S. et al. 1979. Proc. Natl. Acad. Sci. 76, 3159.
      Collett, M.S. and Erikson, R.L. 1978. Proc. Natl. Acad. Sci. 75, 2021.
      Collett, M.S., et al. 1978. Cell 15, 1363.
      Citation
    • Meenalakshmi M. Mariappan, et al. (2005) Phospholipase Cγ-Erk Axis in Vascular Endothelial Growth Factor-Induced Eukaryotic Initiation Factor 4E Phosphorylation and Protein Synthesis in Renal Epithelial Cells. Journal of Biological Chemistry 280, 28402-28411.
    • Justin M. Summy, et al. (2005) AP23846, a novel and highly potent Src family kinase inhibitor, reduces vascular endothelial growth factor and interleukin-8 expression in human solid tumor cell lines and abrogates downstream angiogenic processes. Molecular Cancer Therapeutics 4, 1900-1911.
    • Jose G. Trevino, et al. (2005) Expression and activity of Src regulate interleukin-8 expression in pancreatic adenocarcinoma cells: implications for angiogenesis. Cancer Research 65, 7214-7222.
      		•
      Application referencesImmune Kinase Reaction Bolen, J.B. et al. 1985. Proc. Natl. Acad. Sci. 82, 7275. Immunoblotting Lipsich, L.A., et al. 1983. J. Virol. 48, 352. Grandori, C., and Hanfusa, H. 1988. J. Cell Biol. 107, 2125. Immunoprecipitation Grandori, C., and Hanfusa, H. 1988. J. Cell Biol. 107, 2125. Lipsich, L.A., et al. 1983. J. Virol. 48, 352. Original Clone Lipsich, L.A., et al. 1983. J. Virol. 48, 352.